Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

NCRI 2018 | Highlighting a subset of TNBC for targeted therapy

Adrian Harris • 4 Nov 2018
NCRI 2018
Breast Cancer

Adrian Harris, MD, DPhil, from the University of Oxford, Oxford, UK, speaks at the 2018 National Cancer Research Institute (NCRI) Cancer Conference, held in Glasgow, UK, about a challenge associated with the treatment of triple negative breast cancer (TNBC). Prof. Harris highlights a challenge in treating those with residual disease after therapy. An approach to understanding the molecular mechanisms underlying TNBC and thus identify targets in individual patients is discussed as a way forward.

More from Adrian Harris

Current treatment landscape of triple negative breast cancer
2:47
Current treatment landscape of triple negative breast cancer
Adrian Harris • 4 Nov 2018

Related Videos

How will SARMs fit into the current breast cancer treatment paradigm?
1:14
How will SARMs fit into the current breast cancer treatment paradigm?
Rafael Grochot • 2 Jul 2026
Phase I/II trial of vosilasarm and endocrine therapy in AR+/ER+/HER2− breast cancer
1:35
Phase I/II trial of vosilasarm and endocrine therapy in AR+/ER+/HER2− breast cancer
Rafael Grochot • 2 Jul 2026
HYPORT: does the number of fractions of RNRT impact the typical symptoms experienced?
1:07
HYPORT: does the number of fractions of RNRT impact the typical symptoms experienced?
Sanjoy Chatterjee • 17 May 2026
Design and aim of the HYPORT study in regional nodal breast cancer
1:23
Design and aim of the HYPORT study in regional nodal breast cancer
Sanjoy Chatterjee • 17 May 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals